Exposure to triclosan (TCS), an antibacterial agent, during pregnancy is associated with hypothyroxinemia and decreases in placental glucose transporter expression and activity. The objective of this study was to investigate the influence of TCS on glucose homeostasis and insulin sensitivity in gestational mice (G-mice) and nongestational female mice (Ng-mice) as a control. Herein, we show that the exposure of G-mice to TCS (8 mg/kg) from gestational day (GD) 5 to GD17 significantly increased their levels of fasting plasma glucose and serum insulin, and insulin content in pancreatic b-cells with reduced homeostasis model assessment (HOMA)-b index and increased HOMA-IR index. Area under curve (AUC) of glucose and insulin tolerance tests in TCS (8 mg/kg)-treated G-mice were markedly larger than controls. When compared with controls, TCS (8 mg/kg)-treated G-mice showed a significant decrease in the levels of thyroxine and triiodothyroninelevels, PPARc and glucose transporter 4 (GLUT4) expression, and Akt phosphorylation in adipose tissue and muscle. Replacement of L-thyroxine in TCS (8 mg/kg)-treated G-mice corrected their insulin resistance and recovered the levels of insulin, PPARc and GLUT4 expression, and Akt phosphorylation. Activation of PPARc by administration of rosiglitazone recovered the decrease in Akt phosphorylation, but not GLUT4 expression. Although exposure to TCS (8 mg/kg) in Ng-mice reduced thyroid hormones levels, it did not cause the insulin resistance or affect PPARc and GLUT4 expression, and Akt phosphorylation. The findings indicate that the exposure of gestational mice to TCS (!8 mg/kg) results in insulin resistance via thyroid hormones reduction.
Gestational diabetes mellitus (GDM), defined as the new onset or new diagnosis of glucose intolerance during pregnancy, is one of the most common medical complications of pregnancy. GDM affects approximately 14% of pregnancies in the USA, and is a risk factor for type 2 diabetes in the mother (Jovanovic and Pettitt, 2001; Metzger et al., 2007) . The prevalence of GDM may range from 4.3% to 17.5% of pregnant women in China (Yang et al., 2009; Zhu et al., 2013) . The investigations from in vivo and animal studies demonstrated that hyperglycaemia during pregnancy had an adverse impact on embryogenesis as early as the preimplantation stages of development (Moley et al., 1999) . The advanced maternal age, pre-pregnancy overweight or obesity and a family history of diabetes have been confirmed to be risk factors for GDM (Ben-Haroush et al., 2004; Metzger et al., 2007) .
Triclosan (TCS) is an antibacterial agent that is widely used in soaps, toothpastes, first-aid products, fabrics, and plastic goods. Given its heavy presence in many common household products, it is detectable in surface water, sediment, biosolids, soil, and many aquatic species (Chalew and Halden, 2009; Reiss et al., 2009) . As a result, humans are widely exposed to TCScontaining products. TCS is absorbed mainly through the skin and by oral exposure (Moss et al., 2000; Sandborgh-Englund et al., 2006) . To this end, TCS has been measured in 100% and 51% of urine and cord blood samples, respectively, that were obtained from 181 expectant mothers in New York (Pycke et al., 2014) . High urinary TCS levels are also reported in spontaneous abortion patients (Wang et al., 2015) .
Late gestation is characterized by accelerated growth of fetoplacental unit, rising plasma concentrations of several diabetogenic hormones and increasing insulin resistance (Boden, 1996) . TCS may influence human insulin sensitivity and lead to adiposity (Cani et al., 2007) . Recently, there has been concern over the potential for TCS to disrupt endocrine systems, including thyroid hormone homeostasis (Zorrilla et al., 2009) . We have reported that treating pregnant mice with TCS at a dose of 8 mg/ kg results in decreases of serum thyroxine (T4) and triiodothyronine (T3) levels of approximately 24% and 17%, respectively (Cao et al., 2017) . Hypothyroidism disorders and gestational diabetes are the most common endocrinopathies diagnosed during pregnancy (Oguz et al., 2015) . Hypothyroidism is a known risk factor for gestational diabetes (Gong et al., 2016; Haddow et al., 2016) . Several studies have reported associations between GDM and low free T4 during the second and third trimesters (Olivieri et al., 2000; Velkoska Nakova et al., 2010) . Moreover, ClearyGoldman et al. (2008) found an association between hypothyroxinemia and subsequent GDM during the second trimester. Glucose transporter 4 (GLUT4) is the predominant insulinresponsive glucose transporter isoform. It plays a key role in the process of transporting extracellular glucose into insulinsensitive cells (Zorzano et al., 2005) . Importantly, thyroid hormone is known to up-regulate the expression of GLUT4, thereby increasing insulin-stimulated glucose uptake (Gray et al., 2002; Raychaudhuri et al., 2014) .
Past work from our lab revealed that exposure of gestational mice to TCS (8 mg/kg) caused hypothyroxinemia and decreased the expression and activity of placental glucose transporter (Cao et al., 2017) . As such, the aim of this study was to investigate the influence of TCS exposure during pregnancy on glucose homeostasis and insulin sensitivity. To this end, we examined the glucose homeostasis and insulin resistance in gestational day (GD) 17 mice (G-mice) treated with TCS (1, 4, or 8 mg/kg) from GD5 and nongestational female mice (Ng-mice) exposed to TCS (8 mg/kg). Using biochemical methods, we further examined the effect of TCS on the thyroid and reproductive hormone levels, the expression of GLUT4 and peroxisome proliferatoractivated receptor c (PPARc). Our results consistently suggest that exposure of gestational mice to TCS (!8 mg/kg) causes insulin resistance through thyroid hormone reduction.
MATERIALS AND METHODS
Animals and drug administration. This study was approved by the Animal Care and Ethical Committee of the Nanjing Medical University. All animal handling procedures followed the guidelines of the Institute for Laboratory Animal Research of the Nanjing Medical University. Three-month-old female and male ICR mice (Oriental Bioservice Inc., Nanjing, China), weighing approximately 30-35 g, were used in this study. All of the mice were housed under a 12/12-h light/dark cycle (lights on at 06:00 h) with free access to food and tap water. Vaginal plug detection was chosen as the indicator of GD1. TCS (Sigma-Aldrich Inc., St Louis, Missouri, USA) was dissolved in 100% dimethylsulfoxide (DMSO), and then diluted with corn oil to make 3 different concentrations. At the beginning of experiment (GD5) the TCS concentrations were 0.015%, 0.06%, and 0.12%. As the increase in the body weight of gestational mice, the concentrations of TCS were gradually adjusted (eg, 0.025%, 0.1%, and 0.2% TCS concentrations on GD17) to keep a constant ingested volume (about 200 ll per mouse). The mice were given daily the ingestion of TCS solution at the dose of 1, 4 or 8 mg/kg from GD5 to GD17. The doses and time of the TCS exposure were chosen based on the previous studies that the urinary TCS levels in the gestational mice treated with 10 mg/kg TCS from GD6 to GD11 is equivalent to those of spontaneous abortion patients with high TCS level (Wang et al., 2015) , and the exposure to 8 mg/kg TCS from GD6 to GD18 causes the deficits in the activity and expression of placental glucose transporters (Cao et al., 2017) .
Levothyroxine (L-T4) (Sigma-Aldrich Inc., St Louis, Missouri, USA) was dissolved in 0.9% saline solution and subcutaneously (s.c.) injected (20 lg/kg). PI3K inhibitor LY294002 (Sigma-Aldrich Inc.) dissolved in 0.5% DMSO was intraperitoneally (i.p.) injected (10 mg/kg) (Lee et al., 2017) . PPARc agonist rosiglitazone (rosi, Enzo, Farmingdale, New York) was dissolved in DMSO, and then diluted in 0.9% saline solution to a final concentration of 0.5% DMSO. Oral administration (p.o.) of rosi (5 mg/kg) was given (Zhou et al., 2014) . Control pregnant mice received identical volumes of vehicle. Three-month-old nongestational female mice were also used in this study for normal controls.
Serum hormone measurements. The orbital blood was obtained under anesthetized conditions with chloral hydrate (400 mg/kg, i.p.). The serum was separated by centrifugation at 4
C and stored at À80 C until assay. Total and free T4 and total T3, as well as estrogen (E2) and progesterone (P4) were measured using commercial enzyme-linked immunosorbent assay (ELISA) kits (Uscn Life Science Inc., Houston, USA), according to the manufacturer's instructions. The sensitivities were 1.4 ng/ml for tT4, 47.1 pg/ml for tT3, 0.2 ng/dl for free T4, 2.0 pg/ml for E2, 0.2 ng/ml for P4, respectively. The intra-and inter-assay coefficients of variation were 4.3% and 7.5% for tT4, 4.5% and 7.2% for tT3, 4.6% and 6.3% for free T4,6.0% and 5.8% for E2, 5.8% and 8.4% for P4.
Measurement of plasma glucose and insulin. After mice were fasted for 6 h, the blood was obtained from tail vein, and then the level of plasma glucose was analyzed by glucose oxidase method (Contour Glucometer; Bayer, Toronto, Canada). The orbital blood was obtained, and then level of fasting serum insulin (FSI) was analyzed by enzyme-linked immunosorbent assay (ELISA; Mouse Insulin, Mercodia, Winston-Salem, North Carolina, USA). Intra-and inter-assay coefficients of variation were 1.67% and 2.25% for insulin. The homeostasis model assessment (HOMA) is derived from a mathematical assessment of the balance between hepatic glucose output and insulin secretion from fasting levels of glucose and insulin (Song et al., 2007) . HOMA of b-cell function (HOMA-b) index was calculated by using the formula of 20*FSI/(FPG-3.5). HOMA of insulin resistance (HOMA-IR) index was calculated by using the formula of FPG*FSI/22.5 (Xie et al., 2015) .
Glucose tolerance test and insulin tolerance test. Glucose tolerance test (GTT) was performed as described in previously published studies (McIlwrath and Westlund, 2015) . After mice were fasted for 12 h, 5 ml of blood was obtained from the tail tip before and at 15, 30, 60, and 120 min after injection (i.p.) of D-glucose (2 g/kg, Sigma-Aldrich, St Louis, Missouri, USA), respectively, to measure blood glucose level. Insulin tolerance test (ITT) was conducted as described in previously published studies (Head et al., 2012) . Briefly, mice were fasted for 6 h after which 1 IU/kg body weight of human recombinant insulin (Novolin-R, Novo Nordisk, Plainsboro, New Jersey, USA) was injected (i.p.). Five ml of blood was obtained from the tail tip before insulin administration and at 15, 30, 60, and 120 min after insulin injection.
GTT and ITT curves during the 0-120 min experimental time window were constructed and area under curve (AUC) was calculated.
Insulin immuno-staining. Mice were euthanized with pentobarbital (3 mg/100 ml, i.p.). Their pancreas were dissected and weighed, and then fixed in Bouin's fluid. After dehydration through a graded ethanol series, the samples were processed for paraffin embedding and then serially cut. The sections (5 lm) were deparaffinized and treated with 3% normal goat serum, and then incubated with mouse anti-insulin antibody (1:1000, Millipore, Billerica, Massachusetts, USA) at 4 C overnight. The sections were incubated in biotin-labeled goat antimouse IgG antibody (1:500, Bioworld Technology, Inc., St Louis Park, Minnesota, USA) for 2 h. Immunoreactivities were visualized using an avidin-biotin horseradish peroxidase complex (Vector Laboratories, Inc., Burlingame, California, USA) and observed using a conventional light microscope (DP70, Olympus Optical, Tokyo, Japan). Immunoreactivities were calculated by optical density of insulin (the value of IOD) using Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, Maryland, USA).
Western blot analysis. The muscle and adipose tissues were homogenized to obtain protein samples. Then, the proteins (50 lg) were resolved by SDS-PAGE, transferred onto PVDF membranes, and probed with antibodies of anti-phosphorylation to Akt and anti-PPARc (1:1000, Cell Signaling Technology, Inc., USA) at 4 C overnight. The membranes were then incubated with an HRPlabeled secondary antibody and developed using an ECL detection kit (Millipore, Massachusetts, USA). Following visualization, the blots were stripped by incubation in stripping buffer (Restore, Pierce) for 5 min, and then incubated with antibodies of anti-Akt or anti-b-actin (1:1000, Cell Signaling, Inc., USA). Western blot bands were scanned and analyzed by Image J software (National Institutes of Health, USA).
Reverse transcription quantitative polymerase chain reaction. Total RNA was extracted from muscle and adipose tissues using Trizol (Invitrogen, Carlsbad, California, USA) according to the manufacturer's instructions. RNA (1 lg) was used for reverse transcription using high-capacity cDNA of the reverse transcription kit RT (TaKaRa Biotechnology CO., Ltd, Japan) according to the manufacturer's instructions. The cDNA synthesis run was in triplicate. Forty replicates were used for the quantitative polymerase chain reaction (qPCR) reaction. The GLUT4 and PPARc mRNA primer sequences were designed according to earlier publications (Xu et al., 2015; Zhou et al., 2014) . RT-qPCR was performed using a Light Cycler Fast Start DNA Master SYBR Green I Kit and an ABI Prism 7300 Sequence Detection System (Applied Biosystems, Foster City, California, USA), and relative gene expression was determined using the 2-DDct method with normalization to GAPDH expression. The results were averaged from 4 sets of independent experiments.
Data analysis/statistics. All group data from Figures 1-6 are expressed as the mean 6 SEM; all group data in Table 1 are expressed as the mean 6 SD. All of the statistical analyzes were performed using SPSS 16.0 software (SPSS Inc., Chicago, Illinois, USA). Difference between 2 groups was evaluated using Student's t test. When analyzing 1-variable experiments with more than 2 groups, differences among means were analyzed using 1-factor analysis of variance (ANOVA) followed by Bonferroni post hoc tests. Actual F and p values of ANOVAs and P values of post hoc pairwise comparisons are presented in the results section. Differences at p < .05 were considered statistically significant (Ludwig et al., 2017) .
RESULTS

TCS Caused Hyperglycemia With High Insulin in G-Mice
All gestational mice (G-mice) were randomly divided into 4 experimental groups and were individually treated with vehicle (control) or TCS at 1 of 3 doses (1, 4, or 8 mg/kg/d) from gestation day (GD) 5 to GD17. In this study, non-gestational mice (Ngmice) of the same age received vehicle or TCS (8 mg/kg/d) for 13 days as a control. The TCS exposure for 13 days in neither Gmice (F [3, 36] ¼ 0.342, p ¼ .795; Figure 1A) Figure 1C ) in G-mice were affected by TCS exposure. The levels of FPG (p ¼ .001) and FSI (p ¼ .034) in TCS (8 mg/ kg)-treated G-mice were significantly higher than those in control G-mice, which was also associated with a decrease in the HOMA-b index (F [3, 36] ¼ 3.316, p ¼ .037; Figure 1D ). However, the levels of FPG (p ¼ .683, n ¼ 10) or FSI (p ¼ .831, n ¼ 10) had no differences between control and TCS (8 mg/kg)-treated Ng-mice. Notably, the levels of FSI (p ¼ .024, n ¼ 10) and the HOMA-b index (p ¼ .014, n ¼ 10) in control G-mice were elevated compared with control Ng-mice. As shown in Figure 1E , the immunoreactivity of pancreatic b-cells stained with insulin antibody was stronger in TCS (8 mg/kg)-treated G-mice than that in control Gmice. The IOD value reflected intracellular insulin content was increased by approximately 40% in TCS (8 mg/kg)-treated Gmice (p ¼ .026; n ¼ 10).
TCS Caused Insulin Resistance in G-Mice
An HOMA-IR index was used to evaluate insulin resistance in experimental animals. There was a main effect of TCS exposure for the HOMA-IR index in G-mice (F [3, 36] ¼ 5.505, p ¼ .003; Figure 2A ). TCS (8 mg/kg)-treated G-mice had a significant increase in the HOMA-IR index compared with control G-mice (p ¼ .006, n ¼ 10). In contrast, the HOMA-IR index in TCS (8 mg/kg)-treated Ng-mice did not differ when compared with control Ngmice (p ¼ .09, n ¼ 10). Although control G-mice had a tendency to increase HOMA-IR index, the group when compared with control Ng-mice failed to reach the significance (p ¼ .21, n ¼ 10).
To investigate whether the exposure of G-mice to TCS affects the insulin sensitivity, we further examined GTT and ITT. As shown in Figure 2B , peak glucose levels were reached 15 min following glucose injection in control and TCS (8 mg/kg)-treated G-mice or Ng-mice. Notably, at 15 min (p ¼ .009, n ¼ 10), 30 min (p ¼ .002) and 60 min (p ¼ .003) after the glucose challenge the glucose levels in TCS (8 mg/kg)-treated G-mice were higher relative to controls. Following insulin administration (0.75 IU/kg), blood glucose levels at all tested time points (0 min: p ¼ .016, n ¼ 10; 15 min: p ¼ .004; 30 min: p ¼ .007; 60 min: p ¼ .019; 120 min: p ¼ .042; Figure 2C ) were higher in TCS (8 mg/kg)-treated G-mice when compared with control G-mice. Area under the curve (AUC) of either GTT (F [3, 36] ¼ 9.499, p < .001: Figure 2B ) or ITT (F [3, 36] ¼ 4.962, p ¼ .006; Figure 2C ) was affected by TCS exposure in G-mice, but not Ng-mice (p ¼ .519 or p ¼ .309, n ¼ 10). AUC of both GTT (p ¼ .003, n ¼ 10) and ITT (p ¼ .006, n ¼ 10) were increased in TCS (8 mg/kg)-treated G-mice when compared with control G-mice.
TCS Caused Hypothyroxinemia in G-Mice
To explore the possible mechanisms underlying TCS-induced insulin resistance, we measured the levels of both serum thyroid and gonadal hormones in each group (n ¼ 10; Table 1 ). There was a main effect of TCS exposure in G-mice for the levels of total T3 (tT3, F [3, 36] (p ¼ .618 ) at diestrus had no significant difference between control and TCS-treated Ng-mice. Notably, levels of either thyroid hormones (tT4: p < .001; tT3: p < .001; fT4: p ¼ .006) or gonadal hormones (E2: p < .001; P4: P ¼ .001) in control G-mice were higher than control Ng-mice.
L-Thyroxine Corrected TCS-Induced Insulin Resistance in G-Mice
Low T4 and T3 levels have been shown to be significantly associated with GDM in both the second and third trimesters (Gong et al., 2016; Oguz et al. 2015) . To investigate whether TCSreduced thyroid hormones are involved in insulin resistance of gestational mice, TCS (8 mg/kg)-treated G-mice were given daily injections (s.c.) of L-thyroxine (L-T4, 20 lg/kg) from GD5 to GD17 (n ¼ 10 per experimental group). Results showed that the L-T4 replacement in TCS (8 mg/kg)-treated G-mice not only recovered the levels of FPG (p ¼ .008; Figure 3A) , FSI (p ¼ .042; Figure 3B ), and HOMA-b index (p ¼ .043; Figure 3C ), but also corrected the increases in the HOMA-IR index (p ¼ .004; Figure 3D ), AUCs of GTT (p ¼ .001; Figure 3E ), and ITT (p ¼ .004; Figure 3F ). In contrast, treatment with L-T4 in control G-mice did not alter the levels of FPG (p ¼ .543) and FSI (p ¼ .243) and failed to affect the insulin sensitivity (HOMA-b index: p ¼ .383; HOMA-IR index, p ¼ .468).
TCS-Reduced PPARc Expression in Skeletal Muscle and Adipose Tissue of G-Mice
Past work has shown that T3 receptor activation can enhance PPARc expression in adipose tissue (Weitzel et al., 2003) . PPARc is a transcription factor that can mediate intracellular insulin signaling in most insulin target organs, including skeletal muscle and adipose tissue. PPARc expression has been shown to be reduced in GDM placentas (Knabl et al., 2014) . To test the relationship with PPARc, we examined levels of PPARc expression in adipose tissue and muscle using RT-PCR and Western blot analysis (mRNA: n ¼ 10; protein: n ¼ 6 per experimental group).
Levels of PPARc mRNA (muscle: p ¼ .029; adipose: p ¼ .005; Figure 4A ) and PPARc protein (muscle: p ¼ .009; adipose: p ¼ .007; Figure 4C) Figure 4B ) nor PPARc protein (muscle: P ¼ 0.606; adipose: p ¼ .874; Figure 4D ) was altered by the TCS exposure (8 mg/kg).
TCS Affected Akt Phosphorylation in G-Mice
Reduced Akt-mTOR signaling that results from TCS-induced hypothyroxinemia in gestational mice is able to impair placental development and nutrient transfer (Cao et al., 2017) . Given this, we next sought to examine the state of Akt phosphorylation (phosphor-Akt) in muscle and adipose tissue (n ¼ 6 per experimental group). We found that phosphor-Akt levels in muscle (p ¼ .026; Figure 5A ) and adipose tissue (p ¼ .011) in Gmice were reduced with the TCS exposure (8 mg Figure 5B ).
TCS Affected GLUT4 Expression in G-Mice
GLUT4 plays an important role in the regulation of insulinstimulated glucose uptake, which is regulated by both Akt signaling and thyroid hormones (Zorzano et al., 2005) . This connection was further validated, as GLUT4 mRNA levels in TCS (8 mg/ kg)-treated G-mice were significantly lower than in controls (muscle: p ¼ .029; adipose: p ¼ .011, n ¼ 10; Figure 6A ). This reduction was recoverable with L-T4 replacement (muscle: p ¼ .016; adipose: p ¼ .022, n ¼ 10), which was not dependent on PI3K-Akt signaling (muscle: p ¼ .542; adipose: p ¼ .719, n ¼ 10). However, rosi administration to TCS (8 mg/kg)-treated G-mice had no effect on the reduction of GLUT4 expression (muscle: p ¼ .958; adipose: p ¼ .933, n ¼ 10). In addition, the level of GLUT4 mRNA was not significantly different between control and TCStreated Ng-mice (muscle: p ¼ .860; adipose: p ¼ 0.836, n ¼ 10; Figure 6B ).
DISCUSSION
Insulin resistance is defined as a failure to respond normally to the action of insulin, which impairs insulin-mediated glucose uptake and leads to an increased insulin requirement. The principal findings in this study are that exposure to TCS (!8 mg/kg) during pregnancy (GD5-GD17) can result in insulin resistance. This conclusion is based on the following: (1) TCS administration (8 mg/kg) to G-mice but not Ng-mice caused a significant increase in the levels of FPG. (2) FSI levels and insulin content in pancreatic b-cells were significantly elevated in TCS (8 mg/kg)-treated G-mice but not Ng-mice. This was coupled with a Cao et al. (2017) recently reported that treating pregnant mice with TCS at a dose of 8 mg/kg elicited tT4 and tT3 decreases of approximately 24% and 17%, respectively. The results obtained from this study showed that the exposure to TCS (8 mg/kg) in either G-mice or Ng-mice caused the decreases in the levels of serum tT4, tT3, and fT4 compared with control G-mice and Ng-mice, whereas it did not alter levels of the reproductive hormones E2 and P4. TCS-induced decrease of tT4 level in rats is known to be due to hepatic catabolism potentiation (Paul et al., 2010) . Additionally, Wu et al. (2016) reported that short-term (1 h) TCS exposure concentration-dependently decreased the sodium/iodide symporter-mediated iodide uptake. It also inhibited the activity of thyroid peroxidase, a critical protein for thyroid hormone synthesis which catalyzes the oxidation of iodide and the addition of iodide to the tyrosine residues of thyroglobulin. Tudela et al. (2012) reported a relationship between hypothyroxinemia and diabetes diagnosed during pregnancy. In the second trimester, subclinical hypothyroidism has been associated with gestational diabetes (Cleary-Goldman et al., 2008) . Indeed, the replacement of L-T4 in TCS (8 mg/kg)-treated G-mice could recover their insulin sensitivity to correct the insulin resistance. However, there was a discrepancy phenomenon showing that the reduced thyroid hormones in Ngmice exposed to TCS (8 mg/kg) failed to cause insulin resistance. Consistent with reports by Crofton et al. (2007) , we observed that the levels of serum tT4, tT3, and fT4 in control G-mice were higher than those in control Ng-mice, because the high thyroid hormones during pregnancy are required for the increased maternal metabolic demands. Nutrients are stored in early pregnancy to meet the feto-placental and maternal demands of late gestation and lactation. Late pregnancy is better characterized as a catabolic state, with decreased insulin sensitivity (increased insulin resistance). In particular, the proliferation and expansion of pancreatic b-cells during pregnancy are crucial for maintaining euglycemia in response to the increased metabolic demands (Banerjee et al., 2016) . When compared with control Ng-mice, control G-mice showed a reduction in the HOMA-b index and increased levels of FSI and HOMA-IR index, although the level of FPG was not significantly different between the 2. Thus, one possible explanation for our results is that gestational mice are more susceptible to TCS-induced thyroid hormones reduction leading to insulin resistance.
GLUT4 plays an important role in maintaining glucose homeostasis in mammals. Down-regulation of its expression in adipocytes is a universal feature of insulin-resistant states (Armoni et al., 2005) . Our results showed that TCS exposure in G-mice dose-dependently reduced GLUT4 expression levels in skeletal muscle and adipocytes. Thyroid hormone receptor is a member of the nuclear steroid hormone receptor super-family and can enhance skeletal muscle GLUT4 expression (Raychaudhuri et al., 2014) . The thyroid responsive element is found in the 5 0 -flanking region of the GLUT4 gene (Richardson and Pessin, 1993; Weinstein et al., 1994) . TCS has been reported to alter the expression levels of thyroid hormone responsive genes in rat pituitary cells (Hinther et al., 2011) . To this end, T4 replacement in TCS (8 mg/kg)-treated G-mice rescued the decreased GLUT4 expression. Thus, these results indicate that TCS-reduced thyroid hormone during pregnancy suppresses GLUT4 expression. Ultimately, these effects lead to the observed insulin resistance. On the other hand, the thyroid hormone receptor activation can trigger the Akt-mTOR signaling pathway (Scarlett et al., 2008) . The down-regulation of placental AktmTOR-P70S6K signaling in TCS mice is corrected by the administration of T4 (Cao et al., 2017) . Consistently, TCS exposure reduced Akt phosphorylation in adipose tissue and muscle, which could be recovered by T4 replacement. T3 may promote glucose uptake via enhanced insulin-induced phosphorylation of Akt in 3T3-L1 adipocytes (Lin and Sun, 2011) . Defects in the insulincascaded PI3K-Akt signaling to impair glucose utilization are believed to play a key role in the pathogenesis of insulin resistance (Shulman, 2000) . Insulin stimulation increases PI3K-Akt signaling activity to enhance glucose disposal through the GLUT4 redistribution. The T4 replacement recovered the TCS-impaired activity of placental glucose transporter, which depends on the activation of PI3K-Akt-mTOR signaling (Cao et al., 2017) . However, PI3K-Akt-mTOR signaling was not involved in T4-rescued GLUT4 expression in TCS (8 mg/kg)-treated G-mice. Therefore, further works are required to explore the influence of TCS-induced down-regulation of Akt-mTOR-P70S6K signaling on translocation and activity of GLUT4 in adipose tissue and muscle. Another interesting finding in this study is that the adipocytes and muscle PPARc expressions were reduced by the exposure to TCS (8 mg/kg) in G-mice rather than Ng-mice, which could be corrected by T4 replacement. Thyroid hormone receptor mutations have been found to both decrease PPARc expression levels as well as disrupt PPARc-mediated gene expression . One of the most important functions of ligandactivated PPARc is enhancement of insulin sensitivity, with association between mutant human PPARc and insulin resistance (Barroso et al., 1999) . There is a direct interaction between PPARc and corresponding nuclear hormone response elements in the promoter/enhancer region of the GLUT4 gene (Wu et al., 1998) . Armoni et al. (2003) have reported that the PPARc represses transcription of the GLUT4 promoter in primary adipocytes and that rosiglitazone exerts its anti-diabetic effects by alleviating this repression. Our results showed that the administration of rosiglitazone in TCS (8 mg/kg)-treated G-mice failed to correct the reduced GLUT4 expression, but it could recover Akt phosphorylation. The activation of PPARc by rosiglitazone exerts an antidiabetic effect through improving insulin sensitivity (Ferre, 2004) . PPARc expression is reduced in GDM placentas (Knabl et al., 2014) . Thus, further studies will be needed to elucidate the effects of reduced PPARc expression during pregnancy on TCSinduced insulin resistance.
In summary, our findings in this study suggest that exposure to TCS (!8 mg/kg) during pregnancy can increase susceptibility to insulin resistance through thyroid hormone reduction. Both GDM and thyroid dysfunction in pregnancy are known to compromise maternal and fetal health. Therefore, this information is helpful in understanding risk factors for this pregnancy complication and preventing GDM among high-risk populations. 
